Histone modifications such as acetylation, methylation and phosphorylation have been implicated in fundamental cellular processes such as epigenetic regulation of gene expression, organization of chromatin structure, chromosome segregation, DNA replication and DNA repair. Males absent on the first (MOF) is responsible for acetylating histone H4 at lysine 16 (H4K16) and is a key component of the MSL complex required for dosage compensation in Drosophila. The human ortholog of MOF (hMOF) has the same substrate specificity and recent purification of the human and Drosophila MOF complexes showed that these complexes were also highly conserved through evolution. Several studies have shown that loss of hMOF in mammalian cells leads to a number of different phenotypes; a G 2 /M cell cycle arrest, nuclear morphological defects, spontaneous chromosomal aberrations, reduced transcription of certain genes and an impaired DNA repair response upon ionizing irradiation. Moreover, hMOF is involved in ATM activation in response to DNA damage and acetylation of p53 by hMOF influences the cell's decision to undergo apoptosis instead of a cell cycle arrest. These data, highlighting hMOF as an important component of many cellular processes, as well as links between hMOF and cancer will be discussed.
Introduction
It is now widely accepted that cancer is both a genetic and an epigenetic disease. In addition to the classical mutations or translocations of oncogenes and tumor suppressors, we are finding changes in the epigenetic profile of most cancers (Esteller, 2006; Ting et al., 2006) . These changes manifest as incorrect methylation of CpG islands of DNA, shifts in the covalent modification patterns of histones or as an impaired ability to remodel nucleosomes (Esteller, 2006; Ting et al., 2006) . Since most of these epigenetic changes are reversible they represent an attractive target for the treatment of cancer. Histone acetylation is among the most studied epigenetic modifications. Acetylation of histones is generally associated with transcriptional activation; however, this modification is also involved in repression of transcription, DNA repair, DNA replication and recombination (Eberharter and Becker, 2002; Carrozza et al., 2003; Yamada et al., 2004) . Core histones H3 and H4 are the main subjects of this modification and can be acetylated at various lysine residues, the amount and specific location of which is controlled by the antagonistic action of histone acetyltransferases (HATs) and histone deacetylases (HDACs). This review will focus on the histone acetyltransferase hMOF (human ortholog of males absent on the first) in normal cell growth and speculate on its potential involvement in cell transformation.
The histone acetyltransferase MOF
MOF is a member of the MYST family (from the founding members; MOZ, Ybf2/Sas3, Sas2 & Tip60) of HATs. This family is of particular interest as its members display quite diverse roles in various nuclear processes (see Table 1 ) and some have also been implicated in carcinogenesis (for review see Yang, 2004) . hMOF is the human ortholog of the Drosophila MOF protein, which is one of the key components of the dosage compensation complex or the male specific lethal (MSL) complex (Hilfiker et al., 1997; Akhtar and Becker, 2000; Smith et al., 2000) . In Drosophila, the MSL complex is composed of at least five proteins (MSL1, MSL2, MSL3, MLE and MOF) and two noncoding RNAs; roX1 and roX2 (for review see Lucchesi et al., 2005; Mendjan and Akhtar, 2007; Rea and Akhtar, 2006; Straub and Becker, 2007) . This complex localizes to hundreds of sites along the male Xchromosome and is required to equalize X-linked gene expression between male flies, with one X-chromosome and female flies with two. Recent biochemical purifications revealed that both the Drosophila and mammalian MOF proteins reside in multi-protein complexes and that most of these interacting proteins are conserved between Drosophila and mammals (Table 2 ; Dou et al., 2005; Smith et al., 2005; Mendjan et al., 2006) . Co-purification of four human MSL proteins (hMSL1, hMSL2, hMSL3 and hMOF) showed that the MSL (Borrow et al., 1996; Carapeti et al., 1998; Champagne et al., 1999 Champagne et al., , 2001 Chaffanet et al., 2000; Kitabayashi et al., 2001; Pelletier et al., 2002; Bristow and Shore, 2003; Deguchi et al., 2003; Kindle et al., 2005; Katsumoto et al., 2006; Thomas et al., 2006; Ohta et al., 2007 Abbreviation: HAT, histone acetyltransferases.
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complex is conserved through evolution. However, it remains to be determined whether non-coding RNA component/s, analogous to the roX RNAs in Drosophila, also associate with the mammalian complex. The remarkable evolutionary conservation of the protein components (Table 2) suggests that MOF-hMOF function is likely to be conserved in both species and the presence of so many interacting partners suggests that these functions may be of diverse nature. In addition to evolutionary conserved interacting partners, both Drosophila and human MOF possess the same enzymatic activity. Both proteins harbor histone acetyltransferase activity that is specific for histone H4 at K16 (Hilfiker et al., 1997; Akhtar and Becker, 2000; Smith et al., 2000 Smith et al., , 2005 Taipale et al., 2005) . This specificity is extraordinary as most other HATs are promiscuous and target several different histone residues (Table 1) . Moreover, since siRNAmediated knockdown of hMOF results in severely reduced or complete loss of H4K16Ac Taipale et al., 2005) , any process mediated through H4K16Ac can potentially be interpreted as being mediated by hMOF.
H4K16Ac in chromatin organization
Histone H4 can be acetylated at several lysine residues (K5, K8, K12 and K16) on its N-terminal tail in all eukaryotes (Allfrey et al., 1968) . K16 acetylation is the most abundant of these modifications in human cells (Munks et al., 1991) . With respect to chromatin organization, there are at least two different mechanisms by which H4K16Ac could exert its influence on chromatin organization (Figure 1 ). According to the charge neutralization model (Grunstein, 1997) , acetylation of lysine residues would neutralize their positive charge and thus decrease the affinity of basic histones for the negatively charged DNA. This same mechanism could extend to an interaction between the basic tails of GST-pull down Sykes et al., 2006) Asterisks indicate the proteins that are also found in Drosophila MOF-containing complexes.
MOF histone acetyltransferase S Rea et al histones H3 and H4 and the acidic regions of H2A and H2B. Thus, acetylation could loosen the association between the DNA and the histones or between different nucleosomes, opening up the chromatin and facilitating the binding/interaction of various factors. Evidence for this mechanism comes from the finding that histone hyperacetylation is known to increase the accessibility of nucleosomal DNA to transcription factors and other co-activators in budding yeast (Anderson et al., 2001) . Furthermore, elegant in vitro studies have shown that synthetic acetylation of H4 at K16 alone is sufficient to inhibit the formation of condensed 30 nm chromatin fibers and cross-fiber interactions (Shogren-Knaak et al., 2006) . A second model is founded on the fact that certain protein motifs are able to recognize specifically chemically modified histone tails. This is the basis for the histone code hypothesis (Turner et al., 1992; Strahl and Allis, 2000; Jenuwein and Allis, 2001) , whereby specific histone modifications, acting alone or in combination, can promote or inhibit binding of proteins/protein complexes to chromatin and thus mediate distinct cellular events. Acetylation of lysines on the histone tail is known to be a binding site for proteins containing a bromo domain (Dhalluin et al., 1999; Jacobson et al., 2000) ; however no in vivo binding protein for H4K16Ac has yet been found. Indeed the mark may function to inhibit binding of certain proteins. For example, Sas2 (something about silencing), the yeast ortholog of MOF (Ehrenhofer-Murray et al., 1997; Reifnyder et al., 1997) , also acetylates histone H4 at K16 (Sutton et al., 2003; Shia et al., 2005) and the presence of high levels of H4K16Ac inhibit binding of Sir3, a protein involved in telomeric gene silencing, thus preventing spreading of heterochromatin inwards from the telomeres (Kimura et al., 2002; Suka et al., 2002; KatanKhaykovich and Struhl, 2005) . Similarly, in Drosophila it was shown that H4K16Ac mediated by MOF is able to interfere with binding of the ISWI ATPase, a protein involved in the compaction of chromatin (Corona et al., 2002) . Interestingly, mixed-lineage leukemia 1 (MLL1) contains a bromo domain and has been proposed to bind H4K16Ac in a model (see below) for the establishment and spreading of transcriptionally active regions . Furthermore, studies in yeast, where the four acetylatable lysine residues of the histone tail were mutated in various combinations, showed that only lysine 16 of the H4 tail had specific transcription consequences. Mutation of the other residues had a cumulative, non-specific effect, suggesting that there is recruitment of a specific factor(s) to H4K16Ac (Dion et al., 2005) . However, further studies will be required to identify whether there are bona fide binding factors/ domains for H4K16Ac.
A link with cancer
An interesting observation linking H4K16Ac to cancer was made recently. When comparing the level of H4K16Ac (and H4K20 methylation) in normal cells to that in cancer cell lines and primary tumors, using various techniques, Fraga et al. (2005) found that cancer cells frequently displayed reduced levels of these modifications. They also showed that this reduction occurred at DNA repetitive regions that are undermethylated. Such hypomethylation of repetitive sequences has previously been linked to chromosomal instabilities (Ehrlich, 2002; Eden et al., 2003) . A thorough investigation into loss/reduction of H4K16Ac in human tumors remains to be performed as the above study leaves some outstanding questions: Does the reduction in acetylation lead to hypomethylation or vice versa? Is hypomethylation of repetitive sequences a root cause of cancer in these scenarios? What is the cause of this decrease in H4K16Ac; loss of a specific HAT, overactivity of a HDAC or another mechanism? It is likely that the reduction in H4K16Ac levels in cancer is connected to hMOF. Loss of hMOF expression through mutation or deletion or even downregulation of its enzymatic activity could explain the H4K16Ac decrease. The involvement of hMOF in such fundamentally important processes as chromatin organization, transcriptional regulation and the DNA damage response (see below) strongly support the idea that loss of this enzyme may be an important step in cell transformation. A large-scale analysis comparing expression of hMOF and H4K16Ac levels in normal and diseased tissue will be required to address this important prediction.
Interestingly, depletion of cellular hMOF by siRNA treatment results in a striking (H4K16Ac-independent) nuclear morphological defect. The nuclei of hMOF depleted cells forms multiple lobules or indentations as visualized by immunofluorescence microscopy of DAPI stained cells (Taipale et al., 2005) . Examples of such a polylobulated phenotype have previously been shown to occur in the laminopathy class of diseases (Liu et al., 2000; Favreau et al., 2003; Goldman et al., 2004) . Changes in the composition of the nuclear lamins, proteins that help form the framework needed for nuclear membrane shape and stability, are recently emerging as a common event in many aspects of cancer development (Prokocimer et al., 2006) . Furthermore, the presence of multiple lobules is one of the criteria used by pathologists in diagnosing certain cancers (Zink et al., 2004) . However, the biological basis for the observed phenotype in hMOF depleted cells remains unclear. Interestingly, a hMOF complex contains the nuclear pore component TPR (Table 2 ; Mendjan et al., 2006) . This provides a link with the nuclear membrane although the relevance of this interaction in this context remains to be seen. Furthermore, this defect in nuclear integrity observed in tumors is likely to be a consequence of cell transformation and not a cause.
Based on recent observations we discuss and hypothesize below as to what the role of hMOF and H4K16Ac is in normal cells and how their loss may be involved in tumorigenesis.
hMOF in transcription regulation
Drosophila MOF mediated acetylation of H4 at lysine 16 (H4K16) correlates with a twofold transcriptional upregulation of male X-chromosomal genes during dosage compensation and is required to balance gene expression between the sexes (Bone et al., 1994; Hilfiker et al., 1997) . Both in vitro and in vivo assays have shown that H4K16Ac mediated by MOF leads to increased transcription (Akhtar and Becker, 2000; Smith et al., 2000) . Considering the high degree of homology between the Drosophila and human MOF proteins (Sanjuan and Marin, 2001 ) and the remarkable conservation of the MOF complexes in both organisms (Mendjan et al., 2006) , it is quite likely that hMOF is also involved in transcriptional regulation. Indeed, following siRNA depletion of hMOF, and a subsequent reduction in H4K16Ac levels, a number of genes showed a significant change in their expression pattern ; S Rea and A Akhtar, unpublished data). Interestingly, depletion of another human MSL ortholog, hMSL1, also strongly decreases the level of H4K16Ac ; M Taipale, and A Akhtar, unpublished data) leading to misregulation of a similar subset of genes affected by hMOF depletion ; S Rea and A Akhtar unpublished data). These data suggest that hMSL1 collaborates with hMOF to bring about this acetylation and thus regulate expression of certain genes. However, the affected genes may not be direct targets of hMOF transcriptional regulation and could be secondary events following loss of some other function of hMOF. In depth gene expression analysis together with identification of the direct target genes of hMOF (and other hMSL proteins) will help to understand if transcriptional regulation is one of the main functions of the hMOF complex and whether misregulation of important genes through loss of hMOF could be a pathway that contributes to cancer.
Further evidence for an involvement of hMOF in the regulation of transcription has come from a recent study where an interaction between MLL1 and hMOF, as part of an MLL1-WDR5 complex, is reported . Interestingly, this MLL1-hMOF interaction was not detected in an independent hMOF purification, although an interaction with WDR5 (a H3K4-methyl binding protein; Wysocka et al., 2005) was found in both studies (Mendjan et al., 2006;  Table 2 ). This difference likely reflects on the stoichiometry/stability of the interactions involved. Based on in vitro transcription assays, chromatin immunoprecipitations and gene expression analysis in combination with hMOF knockdown, it has been proposed that H4K16Ac mediated by hMOF and H3K4 methylation mediated by the MLL1 methyltransferase coordinate to activate transcription in vitro and in vivo . This cooperation suggests a possible model for the establishment and spreading of transcriptionally active domains. Following recruitment of either MLL1 or hMOF the methyl mark or the acetyl mark could be bound by WDR5 or the bromo domain of MLL1 respectively; this could then attract the rest of the complex and modify an adjacent nucleosome, resulting in further recruitment of the complex . This would result in the propagation of an active chromatin domain similar to the SUV39H-HP1 system for forming repressive heterochromatic domains (Lachner et al., 2001) .
Interestingly, MLL1 is a proto-oncogene that is rearranged in a wide variety of human leukemias. These cancers are probably caused by the mis-expression of a number of MLL1-regulated genes, underlining the importance of chromatin-modifying factors in the regulation of gene expression. Moreover, other members of the MYST family of HAT proteins are also involved in transcriptional control and also undergo rearrangements in cancer (see Table 1 ; Borrow et al., 1996; Carapeti et al., 1998; Panagopoulos et al., 2001) . However, such translocations have not been observed for the hMOF locus to date.
hMOF in the DNA damage response
In a similar vein to transcriptional activation, H4K16Ac could also act in the process of DNA repair. By the same mechanisms mentioned above the presence of H4K16Ac would result in an open chromatin structure, which could facilitate repair of DNA damage by allowing repair proteins better access to damaged DNA. Work in yeast has provided some evidence for this involvement. Generating double-strand breaks through the induction of the HO endonuclease resulted in an increase in the levels of H4 acetylation, including at K16, in the area surrounding the breaks. This was in response to homologous recombination mediated repair (Tamburini and Tyler, 2005) . This acetylation correlates with recruitment of various HATs to such sites shortly after the DNA break is induced (Bird et al., 2002) . Deacetylation was found to take place later once the DNA had been repaired, and again correlated with recruitment of HDACs (Tamburini and Tyler, 2005; Utley et al., 2005) . This suggests a role for acetylation/ deacetylation in the opening and closing of chromatin to allow repair and subsequent restoration of chromatin structure. An alternative suggestion is that this acetylation/deacetylation does not contribute to repair per se but acts as a signal to the cell to indicate when repair is completed and may also be involved in some checkpoint (Tamburini and Tyler, 2005) .
More direct evidence that implicates hMOF in cell cycle progression and in the DNA repair process comes from the finding that depletion of hMOF in mammalian cell lines (HeLa and 293T cells) led to accumulation of cells in the G 2 /M phase of the cell cycle Taipale et al., 2005) . This accumulation could be suppressed by the addition of caffeine, an inhibitor of the ATM/ATR pathway, suggesting that hMOF-depleted cells have activated the G 2 /M checkpoint (Taipale et al., 2005) . There are at least three possible causes for the observed G 2 /M arrest phenotype in hMOF-knockdown cells. Firstly, preliminary data have shown that upon depletion of hMOF, there is a modest reduction in transcription of a number of genes (Smith et al., 2005; S Rea and A Akhtar, unpublished data). A reduction in the transcription of genes involved in cell cycle progression could, either directly or indirectly, explain the observed phenotype. However, it still remains to be shown whether the direct targets of hMOF could potentially have a role in the regulation of the cell cycle. Another scenario could be that the hMOFdepleted cells may have a defective S phase checkpoint, therefore leading to the observed G 2 /M accumulation. We can speculate that a hMOF-dependent reduction of H4K16 acetylation, a modification that reaches its highest levels during mid-S phase (Rice et al., 2002) , could affect DNA replication, as during this phase a tight co-ordination between DNA replication and preservation of epigenetic integrity must be achieved (Groth et al., 2007) . An alternative explanation would be that loss of hMOF could impair the cell's ability to repair DNA, thereby activating the G 2 /M checkpoint. Some evidence supporting the latter scenario has recently appeared, although the validity of the first two possibilities remains to be examined.
Upon ionizing irradiation (IR) hMOF-depleted cells display a delay in the kinetics of the DNA repair process, as they retained a higher number of ATMp and gH2Ax (markers of DNA double-strand breaks) foci in comparison to control cells (Taipale et al., 2005) . Moreover, cells expressing a dominant-negative form of hMOF were less efficient in double-strand break repair following IR in comparison to the control cells (Gupta et al., 2005) . These data indicate that an impaired DNA repair process could be the reason for the observed genomic instability and decreased viability seen in the hMOF knockdown cells upon IR (Gupta et al., 2005) . These observations have provided a link between hMOF, cell cycle progression and the DNA repair process. However, the mechanism that connects hMOF to this pathway remains unclear: Does hMOF exert its function through H4K16Ac? Does hMOF have a role in sensing, signaling or repairing DNA damage? Some recent studies suggest that hMOF may be involved in multiple ways, directly and indirectly, in the DNA damage response.
The hMOF-ATM connection
The DNA damage response pathway provides a mechanism for transducing the signal from sensors, the molecules that sense the DNA damage, via transducers to the downstream effectors molecules thereby activating the signaling for cell cycle arrest, DNA repair or apoptosis. ATM protein is a transducer molecule, which in its inactive form exists as an inert dimer or multimer (Bakkenist and Kastan, 2003) . Upon activation, ATM dimers dissociate leading to phosphorylation of several downstream repair proteins. Although the ATM pathway is quite well characterized, the exact mechanism responsible for sensing the damage and activation of ATM remains unclear.
It has been proposed that hMOF plays a role in the activation of ATM in response to DNA damage (Gupta et al., 2005) . In particular, it has been shown through two-hybrid assays and Co-IP experiments that hMOF directly interacts with ATM through its chromo domain and that hMOF inactivation leads to reduction of both ATM autophosphorylation and its kinase activity following IR. Moreover, upon a high dose of IR, there was an hMOF-dependent increase in H4K16 acetylation, which does not depend on the presence of ATM (Gupta et al., 2005) . According to Gupta et al. (2005) these data point to a model where in response to IR there is a hMOF-dependent increase of H4K16Ac, which along with the DNA breaks alters the chromatin structure, this signal is then transduced by hMOF to ATM resulting in its activation. Another possibility is that hMOF could activate ATM directly. As MOF's activity has been shown to increase in response to IR, so might its ability to acetylate other substrates. It is possible that DNA damage causes increased hMOF activity that is then targeted to ATM or some activator of ATM, leading to activation of the ATM pathway. It is clear that further work is needed to elucidate the mechanism of hMOF action upon DNA damage.
The tumor suppressor protein p53 is a substrate of hMOF Interestingly, hMOF has recently been added to the list of acetyltransferases that interact with and modify the p53 tumor suppressor protein, thereby regulating its biological function (for review see Brooks and Gu, 2003; Sykes et al., 2006) . The p53 protein has been characterized as the guardian of the genome, as loss of its function frequently results in malignant progression (Levine, 1997; Vousden and Lu, 2002) . The crucial role of p53 derives from its ability to either trigger cell cycle arrest by stimulating the transcription of growth arrest genes, or to induce apoptosis through the transcriptional enhancement of proapoptotic genes in response to genotoxic stress (Vousden, 2006) . However, the molecular mechanisms underlying this decision are poorly understood.
Recently, it has been reported that acetylation of K120 of p53 (p53K120Ac) can determine whether a cell arrests or undergoes apoptosis and that this acetylation is mediated by the MYST acetyltransferases hMOF and TIP60 (Sykes et al., 2006; Tang et al., 2006) . It is interesting to note that this residue, which is located within the DNA-binding domain of p53 (Cho et al., 1994) , has also been found to be mutated in a limited number of cancers (Meyers et al., 1993; Hashimoto et al., 1999; Hayes et al., 1999; Deissler et al., 2004; Leitao et al., 2004) . The functional significance of p53K120Ac was demonstrated by experiments where K120 acetylation was abolished in cells, either by direct mutation or by depletion of hMOF (or Tip60). This loss selectively blocked transcription of proapoptotic genes such as BAX and PUMA, while the transcription of non-apoptotic targets (p21) was unaffected (Sykes et al., 2006) . Furthermore, upon induction of DNA damage, there was a specific accumulation of the p53K120Ac only in the promoters of proapoptotic genes (Sykes et al., 2006; Tang et al., 2006) . These data indicate that hMOF (or Tip60) dependent K120 acetylation of p53 enhances the transcription of some proapoptotic genes, thus favoring apoptosis. Since both hMOF and Tip60 acetylate p53 at the same residue one could speculate that the cell has evolved some redundancy in its response to serious DNA damage. Specific types or extensive DNA damage would result in the increased activity of these acetyltransferases towards p53, resulting in cell death rather then risking incomplete repair and potentially lethal genomic instabilities. It will be interesting to see whether hMOF-or Tip60-dependent acetylation of p53 depends on the type/extent of DNA damage, the stage of the cell cycle or the cell type.
Conclusion
From the loss of function analyses as well as the interaction studies discussed, it is clear that hMOF is involved in several cellular processes, including regulation of transcription, chromatin organization, cell cycle progression, maintenance of nuclear structure, DNA damage repair and apoptosis. However, the functional significance as well the mechanism through which hMOF exerts its function in these processes remains to be elucidated. Some of these roles, which most likely overlap, may be mediated through its acetylation of histone H4 at lysine 16 and some may be through modifying other substrates. During normal cellular growth, hMOF's main function appears to be the regulation of transcription, but it may also be involved in maintaining nuclear integrity (Figure 1 ). Another important function of hMOF is in the cells response to DNA damage. hMOF mediated H4K16 acetylation could serve as a signal to activate the ATM pathway and/or could alter the chromatin structure thus allowing DNA repair proteins better access to the damaged DNA, whereas upon extensive damage increased hMOF HAT activity would lead to acetylation of p53 thus promoting cell death.
Considering hMOF involvement in such important cellular events it is not surprising that hMOF loss may be involved in tumorigenesis. Its multi-functional character however, makes it difficult to elucidate exactly what contribution it makes to each process. Further, more defined studies, as well as functional assays in vitro and in vivo will be required to understand its role in normal cell growth and whether its loss can contribute to cell transformation.
